Endo Against Insulin Infusion Tg Pancreatitis No Diabetes

---
name: endo-against-insulin-infusion-tg-pancreatitis-no-diabetes
description: This skill advises against routine insulin infusion in patients without diabetes who have triglyceride-induced pancreatitis. Trigger phrases include "Patient has triglyceride-induced pancreatitis without diabetes" and "Considering insulin infusion for pancreatitis management".
---

# Avoid routine insulin infusion for triglyceride-induced pancreatitis without diabetes

## STEP 1 — Gather Information
Collect serum triglyceride level, clinical criteria for pancreatitis (abdominal pain, lipase/amylase ≥3× upper limit of normal), diabetes status (history, HbA1c, fasting glucose), and exclude other causes (alcohol, gallstones, medications).

## STEP 2 — Rule In / Rule Out
If diabetes is present, insulin therapy may be indicated for glucose control; manage diabetes accordingly. If diabetes is absent, proceed to evaluate for triglyceride-induced pancreatitis.

## STEP 3 — Classify or Stratify
If triglyceride level >500 mg/dL and pancreatitis is confirmed, classify as triglyceride-induced pancreatitis. If triglyceride ≤500 mg/dL or alternative etiology found, consider other diagnoses.

## STEP 4 — Decide
For triglyceride-induced pancreatitis without diabetes, advise against routine insulin infusion; instead, provide supportive care (NPO, IV fluids), initiate low-fat diet after resolution, and address underlying hypertriglyceridemia with lifestyle modification or fibrates as appropriate.

## Clinical Guardrails / Mimics / Pitfalls
Do not use insulin infusion solely for triglyceride lowering in non-diabetic patients due to risk of hypoglycemia and lack of proven benefit; reserve insulin for uncontrolled diabetes to normalize glucose; avoid delaying definitive pancreatitis management while awaiting lipid-lowering effects.

## Concrete Clinical Example
A 45-year-old man presents with epigastric pain, lipase 4× ULN, triglycerides 850 mg/dL, HbA1c 5.0%, no diabetes history. He is managed with bowel rest, IV hydration, and later a low-fat diet; insulin infusion is not initiated.

**Source:** Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, 10.1210/clinem/dgaa674